vs

Side-by-side financial comparison of Canterbury Park Holding Corp (CPHC) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

STANDARD BIOTOOLS INC. is the larger business by last-quarter revenue ($19.6M vs $12.4M, roughly 1.6× Canterbury Park Holding Corp). Canterbury Park Holding Corp runs the higher net margin — -3.1% vs -177.4%, a 174.3% gap on every dollar of revenue. On growth, Canterbury Park Holding Corp posted the faster year-over-year revenue change (3.9% vs -11.5%). Canterbury Park Holding Corp produced more free cash flow last quarter ($-611.3K vs $-23.1M). Over the past eight quarters, Canterbury Park Holding Corp's revenue compounded faster (-6.0% CAGR vs -12.2%).

Canterbury Park, is a horse racing track in Shakopee, Minnesota, United States. Canterbury Park Holding Corporation hosts parimutuel wagering on live thoroughbred and quarter horse racing at its facilities in Shakopee and parimutuel wagering on races held at out-of-state racetracks that are simulcast to the racetrack. In addition, the Canterbury Park Card Casino operates 24 hours a day, seven days a week, and is also regulated by the Minnesota Racing Commission. Casino games include blackjack...

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

CPHC vs LAB — Head-to-Head

Bigger by revenue
LAB
LAB
1.6× larger
LAB
$19.6M
$12.4M
CPHC
Growing faster (revenue YoY)
CPHC
CPHC
+15.4% gap
CPHC
3.9%
-11.5%
LAB
Higher net margin
CPHC
CPHC
174.3% more per $
CPHC
-3.1%
-177.4%
LAB
More free cash flow
CPHC
CPHC
$22.5M more FCF
CPHC
$-611.3K
$-23.1M
LAB
Faster 2-yr revenue CAGR
CPHC
CPHC
Annualised
CPHC
-6.0%
-12.2%
LAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CPHC
CPHC
LAB
LAB
Revenue
$12.4M
$19.6M
Net Profit
$-390.1K
$-34.7M
Gross Margin
48.5%
Operating Margin
2.6%
-168.5%
Net Margin
-3.1%
-177.4%
Revenue YoY
3.9%
-11.5%
Net Profit YoY
68.7%
-28.8%
EPS (diluted)
$-0.08
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPHC
CPHC
LAB
LAB
Q4 25
$12.4M
Q3 25
$18.3M
$19.6M
Q2 25
$15.7M
$21.8M
Q1 25
$13.1M
$40.8M
Q4 24
$12.0M
Q3 24
$19.3M
$22.1M
Q2 24
$16.2M
$22.5M
Q1 24
$14.1M
$45.5M
Net Profit
CPHC
CPHC
LAB
LAB
Q4 25
$-390.1K
Q3 25
$487.3K
$-34.7M
Q2 25
$-327.4K
$-33.5M
Q1 25
$-299.2K
$-26.0M
Q4 24
$-1.2M
Q3 24
$2.0M
$-26.9M
Q2 24
$338.3K
$-45.7M
Q1 24
$998.2K
$-32.2M
Gross Margin
CPHC
CPHC
LAB
LAB
Q4 25
Q3 25
48.5%
Q2 25
48.8%
Q1 25
48.4%
Q4 24
Q3 24
54.9%
Q2 24
46.1%
Q1 24
53.1%
Operating Margin
CPHC
CPHC
LAB
LAB
Q4 25
2.6%
Q3 25
5.7%
-168.5%
Q2 25
2.8%
-118.1%
Q1 25
4.9%
-80.8%
Q4 24
-0.8%
Q3 24
18.9%
-120.9%
Q2 24
6.9%
-134.5%
Q1 24
12.5%
-132.2%
Net Margin
CPHC
CPHC
LAB
LAB
Q4 25
-3.1%
Q3 25
2.7%
-177.4%
Q2 25
-2.1%
-153.7%
Q1 25
-2.3%
-63.8%
Q4 24
-10.4%
Q3 24
10.5%
-122.0%
Q2 24
2.1%
-203.3%
Q1 24
7.1%
-70.6%
EPS (diluted)
CPHC
CPHC
LAB
LAB
Q4 25
$-0.08
Q3 25
$0.10
$-0.09
Q2 25
$-0.06
$-0.09
Q1 25
$-0.06
$-0.07
Q4 24
$-0.25
Q3 24
$0.40
$-0.07
Q2 24
$0.07
$-0.12
Q1 24
$0.20
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPHC
CPHC
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$17.1M
$129.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$83.9M
$399.7M
Total Assets
$112.6M
$539.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPHC
CPHC
LAB
LAB
Q4 25
$17.1M
Q3 25
$16.7M
$129.4M
Q2 25
$16.9M
$158.6M
Q1 25
$15.4M
$150.9M
Q4 24
$15.1M
Q3 24
$21.7M
$210.6M
Q2 24
$23.8M
$269.8M
Q1 24
$25.2M
$287.1M
Total Debt
CPHC
CPHC
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
CPHC
CPHC
LAB
LAB
Q4 25
$83.9M
Q3 25
$84.1M
$399.7M
Q2 25
$83.6M
$424.5M
Q1 25
$83.7M
$454.6M
Q4 24
$84.1M
Q3 24
$85.2M
$489.3M
Q2 24
$83.2M
$510.3M
Q1 24
$82.7M
$577.3M
Total Assets
CPHC
CPHC
LAB
LAB
Q4 25
$112.6M
Q3 25
$114.4M
$539.6M
Q2 25
$114.9M
$557.0M
Q1 25
$112.4M
$579.6M
Q4 24
$109.9M
Q3 24
$114.2M
$681.5M
Q2 24
$111.4M
$708.7M
Q1 24
$105.6M
$777.7M
Debt / Equity
CPHC
CPHC
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPHC
CPHC
LAB
LAB
Operating Cash FlowLast quarter
$-103.4K
$-22.2M
Free Cash FlowOCF − Capex
$-611.3K
$-23.1M
FCF MarginFCF / Revenue
-4.9%
-118.1%
Capex IntensityCapex / Revenue
4.1%
4.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.7M
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPHC
CPHC
LAB
LAB
Q4 25
$-103.4K
Q3 25
$1.2M
$-22.2M
Q2 25
$4.4M
$-20.7M
Q1 25
$3.4M
$-30.3M
Q4 24
$-2.8M
Q3 24
$2.3M
$-27.9M
Q2 24
$5.4M
$-39.0M
Q1 24
$1.6M
$-62.5M
Free Cash Flow
CPHC
CPHC
LAB
LAB
Q4 25
$-611.3K
Q3 25
$-395.3K
$-23.1M
Q2 25
$3.2M
$-22.6M
Q1 25
$2.5M
$-35.3M
Q4 24
$-6.7M
Q3 24
$-25
$-30.1M
Q2 24
$1.8M
$-41.0M
Q1 24
$-601.0K
$-63.3M
FCF Margin
CPHC
CPHC
LAB
LAB
Q4 25
-4.9%
Q3 25
-2.2%
-118.1%
Q2 25
20.5%
-103.6%
Q1 25
19.1%
-86.6%
Q4 24
-55.9%
Q3 24
-0.0%
-136.4%
Q2 24
11.1%
-182.2%
Q1 24
-4.3%
-138.9%
Capex Intensity
CPHC
CPHC
LAB
LAB
Q4 25
4.1%
Q3 25
9.0%
4.5%
Q2 25
7.5%
8.7%
Q1 25
6.5%
12.4%
Q4 24
32.6%
Q3 24
11.8%
10.2%
Q2 24
22.2%
8.6%
Q1 24
15.7%
1.7%
Cash Conversion
CPHC
CPHC
LAB
LAB
Q4 25
Q3 25
2.56×
Q2 25
Q1 25
Q4 24
Q3 24
1.12×
Q2 24
15.95×
Q1 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPHC
CPHC

Casino$9.5M76%
Other$1.9M15%
Food And Beverage$1.0M8%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons